Search

everythinglearnresearchcommunity

for

Search:↓

Changes in SHBG levels don't predict diabetes risk reduction.

Combination therapy with oral contraceptives and spironolactone improves hair growth, menstrual issues, and acne in women with PCOS.

5α-reductase inhibitors may worsen sexual drive and spontaneous erections but don't worsen existing erectile or ejaculatory problems.

Men with hormonal imbalances similar to PCOS may have increased risk of metabolic and heart diseases.

Some men with early hair loss may have similar hormonal changes to women with Polycystic ovary syndrome, and could be at risk for developing type 2 diabetes.

Low-dose spironolactone is safe and effective for treating hirsutism.

Taking oral testosterone with or without dutasteride increases testosterone levels and could be an effective treatment for low testosterone.

The contraceptive reduced hair growth and altered hormone levels in hirsute women.

The treatment significantly reduced hair growth and male hormone levels in hirsute women.

Women with persistent acne and high levels of antimullerian hormone are more likely to have polycystic ovarian syndrome.

HSD3B1 gene variant and being overweight linked to hair loss in women with polycystic ovary syndrome.

Baldness in men with prostate cancer is linked to higher levels of certain sex hormones, but chest hair density is not.

The new oral testosterone pill normalized testosterone levels and lowered SHBG in men with low testosterone.

Obesity may contribute to female hair loss by increasing male hormone levels that affect hair follicles.

High triglyceride levels are a key factor affecting testosterone levels in women with PCOS.

Chinese women with PCOS have higher androgen levels, which change with age and weight.

The FG score is better at detecting hyperandrogenism in PCOS patients than testosterone levels or FAI, but testosterone is the recommended test for diagnosis.

FAI is a reliable marker for identifying and monitoring hyperandrogenism in obese adolescent females with PCOS.

Prepubertal girls with hypertrichosis have more sensitive androgen receptors, leading to increased body hair growth.

The treatment temporarily improved symptoms of hyperandrogenism in adolescents.

Both injectable contraceptives lower testosterone and SHBG levels, with NET-EN having a greater effect than DMPA-IM.

Early balding in men might be a male hormonal equivalent of polycystic ovaries syndrome in women.

Cyclosporine A therapy changes sex hormone levels differently in pre-menopausal and post-menopausal women with primary biliary cirrhosis.

Women with hyperandrogenism have higher androgen levels and lower SHBG, which may contribute to conditions like excessive hair growth and early puberty.

Certain hormones can reduce skin oil and hair growth, potentially helping treat acne and excessive hair in women.

Vitamin D may help improve hormone levels in women with PCOS.

Testosterone therapy for postmenopausal women appears safe and may protect against heart disease, but requires constant monitoring and more research for long-term effects.

The review suggests a comprehensive approach to treat hirsutism, focusing on hair removal, medication, and managing emotional effects.

High uric acid levels are more common in PCOS patients, especially those with androgenic PCOS, and are linked with increased cardiovascular risk and other metabolic issues.

PCOS is a common disorder in women linked to infertility and heart issues, with treatment focusing on insulin management, reducing androgens, and lifestyle changes.